Extraction of endometrial RNA, preparation and hybridiza¬ tion of RNA dot blots, and generation of IGFBP-3 hybridiza¬ tion probe were as described by Song et al (1996). The probe was a full-length cDNA encoding human IGFBP-3 (Wood et al, 1988), previously validated for pig tissue RNA by northern hybridization (Lee et al, 1993; Song et al, 1996). RNA dot-blots were subjected fo autoradiography and phosphorimage analysis (Green et al, 1995(Green et al, , 1996 
Introduction
Insulin-like growth factors (IGF)-I and -II are evolutionary conserved regulatory peptides that are believed to play import¬ ant autocrine, paracrine and endocrine roles in cell division, differentiation, metabolism and gene expression (Jones and Clemmons, 1995) . We previously reported that physiological amounts of IGF-I are present in pig uterine luminal fluids (Simmen et al, 1989; Ko et al, 1994a; Green et al, 1995) , which peak to maximal concentrations during days [10] [11] [12] (Rechler, 1993) . IGFBPs (Sell et al, classic IGFBPs was recently described by Oh et al (1996) ; however, a biological function similar to those for other IGFBPs has not been elucidated.
IGFBPs in many biological fluids and cell conditioned culture media are found to be partially proteolysed (Jones and Clemmons, 1995) . Of particular biological significance is the observation that partially proteolysed IGFBPs lose their highaffinity binding for IGF resulting in enhanced release of bound IGF (Blat et al, 1994; Lassarre and Binoux, 1994; Lee and Rechler, 1996) . Previously, we reported that mRNAs encoding IGFBPs 2-6 are synthesized by pig uterine endometrium (Simmen et al, 1992; Song et al, 1996) 
Ligand blotting
Ligand blotting was performed as previously described (Lee et al, 1991; Ko et al, 1994b) . One millilitre of an individual ULF corresponding to day 10, 11, 12, 15 (Lee et al, 1991; Ko et al, 1994b Rechler (1993) and Lee el al (1997 (Lee et al, 1993; Song et al, 1996) . RNA dot-blots were subjected fo autoradiography and phosphorimage analysis (Green et al, 1995 (Green et al, , 1996 
Statistical analysis
Phosphorimage data were subjected to least-squares ANOVA using the General Linear Models procedures of the Statistical Analysis System (SAS, 1985) as described by Green et al (1995, 1996) (Fig. 3) . Therefore, the rapid changes in uterine luminal (Fig. 4, lanes 2 versus 3), suggesting that 'spherical' fluid lacks endogenous IGFBP protease activity. However, IGFBP-3 in 'spherical' ULF disappeared after co-incubation with 'filamentous' ULF (Fig. 4 , lanes 4 versus 5), indicating that the latter contains a protease activity for IGFBPs. This activity was partially inhibited by the metal ion chelator EDTA (Fig. 4, lane 7) , but not by another Fig. 1 mefal ion chelator 1,10-phenanthroline (Fig. 4, lane 8) or by the serine protease inhibitor AEBSF (Fig. 4, lane 6 ). Further characterization of the IGFBP protease activity in 'filamentous' ULF using exogenous hIGFBP-3 as substrate indicated that it was minimally inhibited by the serine protease inhibitor, aprotinin (Fig. 5, lane 4) and strongly by EDTA (Fig.  5, lane 5) . However, unlike members of the matrix metalloproteinase (MMP) family (Salvesen and Nagase, 1989) (Fazleabas et al, 1983; Zavy et al, 1984; Simmen et al, 1989 Simmen et al, , 1990 Simmen et al, , 1992 Roberts et al, 1993; Ko et al, 1994a; Green et al, 1995 Green et al, , 1996 Choi et al, 1996; Yelich et al, 1997 (Lee et al, 1993) activity in 'filamentous' but not 'spherical' ULF using hIGFBP-3 or 'spherical' ULF IGFBPs as exogenous and endog¬ enous substrates, respectively. These observations suggest the involvement of conceptus-secreted oestrogens in the luminal disappearance of IGFBP-3, but not in endometrial IGFBP-3 RNA synthesis or degradation, as might be speculated from the down-regulation by oestrogen of IGFBP-3 mRNA and protein synthesis in rat uterus (Yallampalli et al, 1993; Huynh and Pollak, 1994 5-8 (Cohick et al, 1993; Lassarre and Binoux, 1994; Lee and Rechler, 1996) and, therefore, is regarded as an IGF release mechanism (Giudice, 1995 (Jones and Clemmons, 1995) . Schmid et al. (1991) reported that 31 kDa truncated IGFBP-3 either did not affect or potentiated IGF-induced mitogenesis of human and rat bone cells. Similarly, Andress and Birnbaum (1992) (Green et al, 1995) . It is also possible that IGF-I, with its significant mitogenic activity, promotes conceptus trophoblast or uterine epithelial hyperplasia (Ko et al, 1994b ).
The IGFBP protease activity in pig ULF described here appears distinct from those previously described for other biological fluids such as serum (Fowlkes et al, 1994a; Lee and Rechler, 1996) and follicular fluid (Besnard et al, 1996 (Besnard et al, , 1997 (Lottenberg et al, 1988) , the presence of plasminogen in the uterine lumen at this developmental time (Fazleabas et al, 1983) , and the known IGFBP-3 proteolytic activity of plasmin (Campbell et al, 1993; Lalou et al, 1994) . However, the inability of AEBSF, a known inhibitor of plasmin (Angelloz-Nicoud and Binoux, 1995) , to inhibit the ULF protease activity is not consistent with the plasminogenplasmin activator system. Furthermore, unlike matrix metalloproteinases (Salvesen and Nagase, 1989) 
